- Home
- SNN vs RGC Comparison
SNN vs RGC Comparison
Compare SNN & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SNN | RGC |
|---|---|---|
| Founded | 1856 | 2014 |
| Country | United Kingdom | Hong Kong |
| Employees | 16988 | N/A |
| Industry | Industrial Specialties | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.3B | 11.5B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | SNN | RGC |
|---|---|---|
| Price | $30.62 | $5.05 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $36.25 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 568.6K |
| Earning Date | 03-16-2026 | 10-31-2025 |
| Dividend Yield | ★ 2.48% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.58 | N/A |
| Revenue Next Year | $5.60 | N/A |
| P/E Ratio | $64.97 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $28.56 | $4.67 |
| 52 Week High | $38.79 | $69.00 |
Technical Indicators
Market Signals| Indicator | SNN | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 51.82 | 26.59 |
| Support Level | $29.03 | N/A |
| Resistance Level | $31.06 | $29.26 |
| Average True Range (ATR) | 0.64 | 1.15 |
| MACD | 0.12 | 0.44 |
| Stochastic Oscillator | 70.25 | 12.18 |
Price Performance
Historical ComparisonAbout SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.